Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Jan-Feb;15(1):24-36.
doi: 10.1080/09286580701772037.

The convergence insufficiency treatment trial: design, methods, and baseline data

Convergence Insufficiency Treatment Trial (CITT) Study Group  1
Collaborators, Affiliations
Randomized Controlled Trial

The convergence insufficiency treatment trial: design, methods, and baseline data

Convergence Insufficiency Treatment Trial (CITT) Study Group. Ophthalmic Epidemiol. 2008 Jan-Feb.

Abstract

Objective: This report describes the design and methodology of the Convergence Insufficiency Treatment Trial (CITT), the first large-scale, placebo-controlled, randomized clinical trial evaluating treatments for convergence insufficiency (CI) in children. We also report the clinical and demographic characteristics of patients.

Methods: We prospectively randomized children 9 to 17 years of age to one of four treatment groups: 1) home-based pencil push-ups, 2) home-based computer vergence/accommodative therapy and pencil push-ups, 3) office-based vergence/accommodative therapy with home reinforcement, 4) office-based placebo therapy. Outcome data on the Convergence Insufficiency Symptom Survey (CISS) score (primary outcome), near point of convergence (NPC), and positive fusional vergence were collected after 12 weeks of active treatment and again at 6 and 12 months posttreatment.

Results: The CITT enrolled 221 children with symptomatic CI with a mean age of 12.0 years (SD = +2.3). The clinical profile of the cohort at baseline was 9Delta exophoria at near (+/- 4.4) and 2Delta exophoria (+/-2.8) at distance, CISS score = 30 (+/-9.0), NPC = 14 cm (+/- 7.5), and near positive fusional vergence break = 13 Delta (+/- 4.6). There were no statistically significant nor clinically relevant differences between treatment groups with respect to baseline characteristics (p > 0.05).

Conclusion: Hallmark features of the study design include formal definitions of conditions and outcomes, standardized diagnostic and treatment protocols, a placebo treatment arm, masked outcome examinations, and the CISS score outcome measure. The baseline data reported herein define the clinical profile of those enrolled into the CITT.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Study Design
Figure 2
Figure 2. CI Symptom Survey
Clinician instructions: Read the following subject instructions and then each item exactly as written. If subject responds with “yes”-please qualify with frequency choices. Do not give examples. Subject instructions: Please answer the following questions about how your eyes feel when reading or doing close work.
See this image and copyright information in PMC

References

    1. Scheiman M, Wick B. Clinical Management of Binocular Vision: Heterophoric, Accommodative and Eye Movement Disorders. Philadelphia: Lippincott, Williams and Wilkins; 2002.
    1. Scheiman M, Gallaway M, Coulter R, et al. Prevalence of vision and ocular disease conditions in a clinical pediatric population, in review. J Am Optom Assoc. 1996;67:193–202. - PubMed
    1. Rouse MW, Hyman L, Hussein M, Solan H CIRS group. Frequency of convergence insufficiency in optometry clinic settings. Optom Vis Sci. 1998;75:88–96. - PubMed
    1. Rouse MW, Borsting E, Hyman L, et al. Frequency of convergence insufficiency among fifth and sixth graders. Optom Vis Sci. 1999;76:643–49. - PubMed
    1. Daum KM. Convergence insufficiency. Am J Optom Physiol Opt. 1984;61:16–22. - PubMed

Publication types